Author(s):
Prasanta Kumar Mohapatra, Boddu Pavan Kumar, Pankaj Singh Patel, Harish Chandra Verma, Satyajit Sahoo
Email(s):
mohapatra.kjr@gmail.com
DOI:
10.52711/0974-360X.2021.00894 
Address:
Prasanta Kumar Mohapatra1*, Boddu Pavan Kumar2, Pankaj Singh Patel1, Harish Chandra Verma1, Satyajit Sahoo3
1Moradabad Educational Trust Group of Institutions, Faculty of Pharmacy, Moradabad - 244001, Uttar Pradesh, India.
2Lydia College of Pharmacy, Ravulapalem - 533238, Andhra Pradesh, India.
3C. U. Shah College of Pharmacy and Research, Surendranagar - 363001, Gujrat, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 10,
Year - 2021
ABSTRACT:
Mucoadhesive buccal films of rivastigmine were prepared by the solvent casting technique using HPMC K15M, sodium alginate, glycerine, and Eudragit RL100. Arranged films assessed for weight variation, thickness, % drug substance, % moisture loss, % moisture take-up, folding endurance, in-vitro medicament release, and Fourier transform Infrared spectroscopy (FTIR). The films showed a controlled release (CR) over 8 h. The preparation observed to be a worthy candidate for the development of buccal patches for therapeutic purposes. Drug-polymer compatibility considers FTIR demonstrated no contradiction between the medicament and the polymers. The optimized formulation found F7 indicated drug release 85% at the end of 8 h. Thinking about the correlation coefficient (R2) values got from the kinetic equations, the drug release from the formulations F1-F8 has discovered zero-order release mechanism. It can be concluded that oral buccal patches of rivastigmine, for treatment of Alzheimer’s and Parkinson’s disease, can be formulated. The study suggests that rivastigmine can be conveniently administered orally in the form of buccal patches, with the lesser occurrence of its side effects and improved bioavailability.
Cite this article:
Prasanta Kumar Mohapatra, Boddu Pavan Kumar, Pankaj Singh Patel, Harish Chandra Verma, Satyajit Sahoo. Development and Evaluation of Trans Buccal Patches based on Natural and Synthetic Polymers Loaded with Rivastigmine using Solvent Casting Technique. Research Journal of Pharmacy and Technology. 2021; 14(10):5133-0. doi: 10.52711/0974-360X.2021.00894
Cite(Electronic):
Prasanta Kumar Mohapatra, Boddu Pavan Kumar, Pankaj Singh Patel, Harish Chandra Verma, Satyajit Sahoo. Development and Evaluation of Trans Buccal Patches based on Natural and Synthetic Polymers Loaded with Rivastigmine using Solvent Casting Technique. Research Journal of Pharmacy and Technology. 2021; 14(10):5133-0. doi: 10.52711/0974-360X.2021.00894 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-10-12
REFERENCES:
1. Perrie Y, Rades T. Controlling drug delivery. Pharmaceutics: Drug Delivery and Targeting, London, 2012; 2nd ed: pp. 18-19
2. Brahmankar DM, Jaiswal SB. Controlled release medication. Biopharmaceutics and Pharmacokinetics: Pharmacokinetics, Vallabh Prakashan, Delhi. 2009; 2nd ed: pp. 335-371.
3. Lee VHL. Controlled Drug Delivery Fundamentals and Applications: Influence of Drug Properties on Design, Edited by Robinson JR and Lee VHL. Marcel Dekker, New York. 1987; 2nd ed: pp. 16-25.
4. Patel RP, Patel G, Patel H, Baria A. Formulation and Evaluation of Transdermal Patch of Aceclofenac. Research J Pharma Dosage Forms and Tech. 2009; 1(2): 108-115.
5. United States Pharmacopeial, United States Pharmacopoeia Convention, Rock Ville, Maryland, USA. 1985
6. Pharmaceutical Society of Great Britain. The Pharmaceutical Codex, Pharmaceutical Press, One Lambeth High St. London. England. 1979; 11th ed. pp. 799-801.
7. Jain NK, Ummaheshwari RB. Controlled and Novel Drug Delivery Systems. Pharmaceutical Product Development, CBS Publishers and Distributors, New Delhi, 2006; 1st ed: pp. 419-424.
8. Manogna K, Shilpa TN. Development of Medicated Topical Patches in Transdermal Drug Delivery System. Research J Pharm and Tech. 2018; 11(1): 397-404.
9. Sontakke PU, Dongre KJ, Harsulkar AA, Pratapwar AS, Sakarkar DM. Development and Evaluation of Buccal Film by Studying Various Mucoadhesive Polymers. Research J Pharm and Tech. 2012; 5(2): 243-248.
10. Wade A and Weller PJ. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Washington and The Pharmaceutical Press, London. 1994
11. Camps P, Munoz-Torrero D. Cholinergic Drugs in Pharmacotherapy of Alzheimer's disease. Mini Reviews in Medicinal Chemistry. 2002; 2(1): 11-25.
12. Rosler M, Anand R, Cicin Sain A, Gauthier S, Agid Y, Dal Bianco P, Stähelin HB, Hartman R, Gharabawi M, Bayer T. Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease: International Randomized Controlled Trial Commentary: Another Piece of the Alzheimer's jigsaw. British Medical Journal. 1999; 318: 633-638.
13. Finkel SI. Effects of Rivastigmine on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease. Clinical Therapeutics. 2004; 26(7): 980-990.
14. Rosler M, Retz W, Retz Junginger P, Dennler HJ. Effects of two-year Treatment with the Cholinesterase Inhibitor Rivastigmine on Behavioural Symptoms in Alzheimer's Disease. Behavioural Neurology. 1998; 11: 211-216.
15. Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl GN, De Deyn PP, Durif F, Kulisevsky J, Van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Rivastigmine for Dementia Associated with Parkinson's Disease. New England Journal of Medicine. 2004; 351: 2509-2518.
16. Winblad B, Grossberg G, Frolich L, Farlow M, Zechner S, Nagel J, Lane R. IDEAL: A 6-month, Double-blind, Placebo-controlled Study of the first Skin Patch for Alzheimer disease. Neurology. 2007; 69(1): 14-22.
17. Inglis F. The Tolerability and Safety of Cholinesterase Inhibitors in the Treatment of Dementia. International Journal of Clinical Practice Supplement. 2002; 127: 45-63.
18. Bruschi ML, Freitas Od. Oral Bioadhesive Drug Delivery Systems. Drug Development and Industrial Pharmacy. 2005; 31: 293-310.
19. Suja C, Ramasamy C and Narayanacharyulu R. Development and Evaluation of Lisinopril Transdermal Patches. Research J Pharm and Tech. 2011; 4(8): 1260-1264.
20. Das A, Ghosh S, Das S, Dey BK, and Ghosh TK. Formulation and in vitro Evaluation of Transdermal Patches of Metformin Hydrochloride using Hydrophilic and Hydrophobic Polymer Complex. Research J Pharm and Tech. 2011; 4(4): 561-565.
21. Saha P, Das PS. Formulation Development and Evaluation of Buccal Patches of Aceclofenac for Gingivitis. Res J Pharm Dosage Form. and Tech. 2017; 9(4): 163-167.
22. Goudanavar PS, Bagali RS, Patil SM. Characterization and Evaluation of Glibenclamide Transmucosal Drug Delivery System. Research J Pharma Dosage Forms and Tech. 2010; 2(1): 44-46.
23. Barar J, Salatin S, Jalali MB, Adibkia K, Milani MA, Jelvehgari M. Formulation and Evaluation of Eudragit RL-100 Nanoparticles loaded in-situ Forming Gel for Intranasal Delivery of Rivastigmine. Adv Pharm Bull. 2020; 10: 20-29.
24. Lakshmana MG, Raghu Vamsi V, Tirumala D, Narendra Babu N, Sravya Ch, Masthaniah K, Shaik HR, Kranti Kumar P. Design and Evaluation of Diclofenac Sodium Buccal Mucoadhesive film by Solvent Casting Technique. International Journal of Pharmaceutical Sciences and Research. 2014; 5(5): 1767-1775.
25. Arifa Begum Sk, Sravya AHLB, Deepika BGD, Naga Manasa G, Srujana M, Uma V, Lakshmi Tejeswari S, Padmalatha K. Formulation and Evaluation of Fexofenadine Buccal Mucoadhesive Patches. Research J Pharm and Tech. 2018; 11(11): 4892-4898.
26. Jatav VS, Saggu JS, Sharma AK, Singh SK. Effect of Dimethyl Sulphoxides as Permeation Enhancer on Transdermal Patch of Nebivolol Hydrochloride. Asian J Res Pharm Sci. 2013; 3(1): 08-11.
27. Lal N, Verma N. Development and Evaluation of Transdermal Patches Containing Carvedilol and effect of Penetration Enhancer on Drug Release. Research J Pharm and Tech. 2018; 11(2): 745-752.
28. Semalty M, Semalty A, Kumar G. Formulation and Characterization of Mucoadhesive Buccal Films of Glipizide. Indian J Pharm Sci. 2008; 70(1): 43-48.
29. Adhikari SN, Nayak BS, Nayak AK, Mohanty B. Formulation and Evaluation of Buccal Patches for Delivery of Atenolol. AAPS Pharm Sci Tech. 2010; 11: 1038-1044.
30. Ajina CT, Narayana Charyulu R, Sandeep DS. Rizatriptan Transdermal Patches for the Treatment of Migraine. Research J Pharm and Tech. 2018; 11(3): 873-878.
31. Samanthula KS, Satla SR, Bairi AG. Development, In-Vitro and Ex- Vivo Evaluation of Mucoadhesive Buccal patches of Candesartan cilexetil. Research J Pharm and Tech. 2019; 12(6): 3038-3044.
32. Banu VTS, Som S, Khaleel M, Havannavar NT. Transdermal Drug Delivery System of Salbutamol Sulphate: Formulation and Evaluation. Research J Pharma Dosage Forms and Tech. 2010; 2(1): 56-61.
33. Banu VTS, Som S. Preparation and Evaluation of Transdermal Films of Oxybutynin. Research J Pharma Dosage Forms and Tech. 2009; 1(2): 130-134.
34. Shinde AJ, Garala KC, Garala RJ, More HN. Effect of Cross-linking Agent on the Release of Drug from the Transdermal Matrix Patches of Tramadol Hydrochloride. Research J Pharm and Tech. 2008; 1(3): 187-192.
35. Krishnaveni B, Anna balaji Dr, Vishnuvardhan G. Formulation and Evaluation of Mucoadhesive Buccal Films of Atorvastatin using natural Protein, International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(2): 332-337.
36. Singh S, Jain S, Muthu MS, Tiwari S, Tilak R. Preparation and Evaluation of Buccal Bioadhesive films containing Clotrimazole. AAPS Pharm Sci Tech. 2008; 9(2): 660-667.
37. Solanki SS, Patel KB, Patel JG, Patel MP, Patel JK. Development of Matrix type Transdermal Patches of Granisetron Hydrochloride: Physicochemical and In-Vitro Characterization. Research J Pharm and Tech. 2012; 5(7): 973-977.
38. Jagdale SC, Asawaree HA, Bhanudas KS, and Aniruddha CR. Development and Evaluation of Mucoadhesive Buccal Patches of Nifedipine. Research J Pharm and Tech. 2011; 4(6): 944-948.
39. Ramteke KH, Dighe PA, Kharat AR, Patil SV et al. Mathematical Models of Drug Dissolution: A review. Scholars Academic Journal of Pharmacy. 2014; 3(5): 388-396.
40. Peppas NA, Ritger PL. A simple Equation for Description of Solute Release ii. Fickian and Anomalous Release from Swellable Devices. Journal of Controlled Release, 1987; 5: 37-42.
41. Siepmann J, Siepmann F. Mathematical Modeling of Drug Delivery. International Journal of Pharmaceutics. 2008; 364: 328-343.
42. Peppas NA, Sahlin JJ. A simple Equation for the Description of Solute Release. III. Coupling of Diffusion and Relaxation. International Journal of Pharmaceutics. 1989; 57: 169-172.
43. Singh JV, Singh SJ, Sharma AK, Gilhotra RM, Sharma A, Jat RK. Design, Formulation and in vitro Drug Release from Transdermal Patches containing Nebivolol Hydrochloride as Model Drug. Asian J Pharm Res. 2012; 2(4): 136-141.
44. Pradeep KK, Arshad BK. Buccal Patches: A Review. International Journal of Pharmaceutical Sciences and Research. 2013; 4(1): 83-89.